News and Press releases

News and Press releases

PHARMAFLIGHT delegation in Washington

Gyula Győri, Scientific Director, and Dr. Botond Szűcs, Chief Biologist, spent three days in Washington DC at the end of September at the invitation of the Federal Motor Carrier Safety Administration (FMCSA).

Az Egyesült Államok Közlekedési Minisztériuma WashingtonbanThe U.S. Department of Transportation in Washington D.C.

Members of the delegation met with Associate Administrator for Policy and Program Development Larry Minor and Transportation Specialist Rich Clemente. Also present at the meeting were PHARMAFLIGHT's US business partner, ATA-Associates, CEO Bob Swint, ex-NASA engineer, and Richard Cook, Deputy CEO. The meeting focused on reviewing the details of a future grant proposal and the participants discussed the feasibility of using PHARMAFLIGHT's measurement methodology within the FMCSA's existing and operational fatigue management program.


Privacy Policy / GDPR

This website uses cookies. Please read the privacy policy and if you agree with it, accept it by clicking the OK button.

Detailed list of cookies

This website uses cookies. Please read the Privacy Policy and if you agree with it, accept it by clicking the OK button.

Used for internal PHP usage. Session ID that expires when the browser is closed.

Language of the website. This value is always HU or EN on the website. Used by the administration system. Expires after 1 month.

GDPR acceptance status. Expires after 3 months.

For registered users who are logged in for a long period of time, this contains a unique identifier that can be used to log in the user every time the browser is reopened (or when the session expires).